This is copied from Dr Robert Bransfield's Facebook page but much of the content is being shared on Facebook from many sources.
CDC Fraud Exposed
The trade marked phrase of the CDC is “Saving Lives, Protecting People” however failures within the CDC have resulted in a number of major failures such as biohazard lab failures, the high titer Edmonston-Zagreb measles vaccine studies and the financially biased and scientifically unsound reliance upon the poor quality two tiered Lyme disease testing.
A recent peer reviewed article by BS Hooker demonstrates the concerns about the MMR vaccine noted by Andrew Wakefield had scientific validity and the attempts to discredit him had not scientific merit. The article is called: Measles-mumps-rubella vaccination timing and autism among young African American boys: a reanalysis of CDC data and is posted on MedLine at: http://www.ncbi.nlm.nih.gov/pubmed/25114790 A vide expanding upon the issues is at:http://vimeo.com/user5503203/review/103711143/91f7d3d4d8 Since the video has been released it has started a firestorm of controversy:http://www.foiacentre.com/news-MMR-070305_2.htmlhttp://jonrappoport.wordpress.com/2014/08/22/breaking-cdc-whistleblower-thompson-in-grave-danger-now/ We need better safeguards to prevent current CEDC fraud. It currently exists in regard to Lyme disease and a thorough investigation is needed.
The trade marked phrase of the CDC is “Saving Lives, Protecting People” however failures within the CDC have resulted in a number of major failures such as biohazard lab failures, the high titer Edmonston-Zagreb measles vaccine studies and the financially biased and scientifically unsound reliance upon the poor quality two tiered Lyme disease testing.
A recent peer reviewed article by BS Hooker demonstrates the concerns about the MMR vaccine noted by Andrew Wakefield had scientific validity and the attempts to discredit him had not scientific merit. The article is called: Measles-mumps-rubella vaccination timing and autism among young African American boys: a reanalysis of CDC data and is posted on MedLine at: http://www.ncbi.nlm.nih.gov/pubmed/25114790 A vide expanding upon the issues is at:http://vimeo.com/user5503203/review/103711143/91f7d3d4d8 Since the video has been released it has started a firestorm of controversy:http://www.foiacentre.com/news-MMR-070305_2.htmlhttp://jonrappoport.wordpress.com/2014/08/22/breaking-cdc-whistleblower-thompson-in-grave-danger-now/ We need better safeguards to prevent current CEDC fraud. It currently exists in regard to Lyme disease and a thorough investigation is needed.
-----------------------------------------------------------------------------------------------
I copy the NIH study below
Transl Neurodegener. 2014 Aug 8;3:16. doi: 10.1186/2047-9158-3-16. eCollection 2014.
Measles-mumps-rubella vaccination timing and autism among young african american boys: a reanalysis of CDC data.
Abstract
BACKGROUND:
A significant number of children diagnosed with autism spectrum disorder suffer a loss of previously-acquired skills, suggesting neurodegeneration or a type of progressive encephalopathy with an etiological basis occurring after birth. The purpose of this study is to investigate the effectof the age at which children got their first Measles-Mumps-Rubella (MMR) vaccine on autism incidence. This is a reanalysis of the data set, obtained from the U.S. Centers for Disease Control and Protection (CDC), used for the Destefano et al. 2004 publication on the timing of the first MMR vaccine and autism diagnoses.
METHODS:
The author embarked on the present study to evaluate whether a relationship exists between child age when the first MMR vaccine was administered among cases diagnosed with autism and controls born between 1986 through 1993 among school children in metropolitan Atlanta. The Pearson's chi-squared method was used to assess relative risks of receiving an autism diagnosis within the total cohort as well as among different race and gender categories.
RESULTS:
When comparing cases and controls receiving their first MMR vaccine before and after 36 months of age, there was a statistically significant increase in autism cases specifically among African American males who received the first MMR prior to 36 months of age. Relative risks for males in general and African American males were 1.69 (p=0.0138) and 3.36 (p=0.0019), respectively. Additionally, African American males showed an odds ratio of 1.73 (p=0.0200) for autism cases in children receiving their first MMR vaccine prior to 24 months of age versus 24 months of age and thereafter.
CONCLUSIONS:
The present study provides new epidemiologic evidence showing that African American males receiving the MMR vaccine prior to 24 months of age or 36 months of age are more likely to receive an autism diagnosis.
KEYWORDS:
Autism; Measles-mumps-rubella (MMR) vaccine
------------------------------------------------------------------------------------------
Just recently this was published
Med Hypotheses. 2014 Jun 16. pii: S0306-9877(14)00233-3. doi: 10.1016/j.mehy.2014.06.005. [Epub ahead of print]
Divergent opinions of proper Lyme disease diagnosis and implications for children co-morbid with autism spectrum disorder.
Kuhn M1, Bransfield R2.
Abstract
This paper proposes that some children with an autism spectrum disorder (ASD) in the United States have undiagnosed Lyme disease and different testing criteria used by commercial laboratories may be producing false negative results. Two testing protocols will be evaluated; first, the Centers for Disease Control (CDC) and Infectious Disease Society of America (IDSA) approved two-tiered Enzyme Immunoassay (EIA) or Immunofluorescence Assay (IFA) followed by an IgM and/or IgG Western Blot test. Second, a clinical diagnosis (flu like symptoms, joint pain, fatigue, neurological symptoms, etc.) possibly followed by a Western Blot with a broader criteria for positive bands [1]. The hypothesis proposes that the former criteria may be producing false negative results for some individuals diagnosed with an ASD. Through an online survey parents of 48 children who have a diagnosis of an ASD and have been diagnosed with Lyme disease were asked to fill out the Autism Treatment Evaluation Checklist (ATEC) before they started antibiotic therapy and after treatment. Of the 48 parents surveyed 45 of them (94%) indicated their child initially tested negative using the two-tiered CDC/IDSA approved test. The parents sought a second physician who diagnosed their child with Lyme disease using the wider range of Western Blot bands. The children were treated with antibiotics and their scores on the ATEC improved. Anecdotal data indicated that some of the children achieved previously unattained developmental milestones after antibiotic therapy began. Protein bands OSP-A and/or OSP-B (Western Blot band 31) and (Western Blot band 34) were found in 44 of 48 patients. These two bands are so specific to Borrelia burgdorferi that they were targeted for use in vaccine trials, yet are not included in the IDSA interpretation of the Western Blot.
Copyright © 2014. Published by Elsevier Ltd.
------------------------------------------------------------------------------------------
and also interesting to hear Dr Jones Interview where he also discusses Lyme and Vaccination in Autistic children too long to copy